| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_887e61d1cb6a16e1d6d099d9fb6aebea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf2d37fb8041db82befb3065684c82b7 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86 |
| filingDate |
2005-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c540fba226c0f413e329ef898c2a9c22 |
| publicationDate |
2006-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006008267-A2 |
| titleOfInvention |
Methods for optimizing forming viiia-based hemostatic treatment |
| abstract |
The present invention relates to pharmacogenomic methods for optimizing prevention and treatment of bleeding episodes using therapeutic proteins such as, e.g., Vitamin K-dependent clotting factors. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11001613-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9873720-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10160961-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9018167-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10201586-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9556230-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9777051-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11266724-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11203749-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10800816-B2 |
| priorityDate |
2004-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |